Skip Navigation

This Article
Right arrow Print PDF (6369K)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Chrysogelos, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chrysogelos, S. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Nucleic Acids Research, 1993, Vol. 21, No. 24 5736-5741
© 1993


MOLECULAR BIOLOGY

Chromatin structure of the EGFR gene suggests a role for intron 1 sequences in its regulation in breast cancer cells

Susan A. Chrysogelos

Lombardi Cancer Research Center and the Department of Biochemistry, S-124A, Georgetown University 3800 Reservoir Road, NW, Washington, DC 20007, USA

Received August 4, 1993. Revised November 2, 1993. Accepted November 2, 1993.

The chromatin structure of the epidermal growth factor receptor gene (EGFR) has been analyzed in several human breast cancer cell lines exhibiting a wide range of EGFR expression. Using DNase I, structural differences were identified in the promoter, first exon, and intron 1 of the EGFR gene that correlate with its expression. Specifically, a DNase I hypersensitive site (DH site) around the exon 1/intron 1 boundary occurred preferentially in estrogen receptor positive breast cancer cell lines with low levels of EGFR expression, while a group of DH sites in intron 1 were observed in estrogen receptor negative, high EGFR expressors. Additionally, a region in the promoter was sensitive to DNase I in all breast cancer cells expressing EGFR, but showed differences in both the level of nuclease sensitivity and the extent of the area that was susceptible. Fine mapping by native genomic blotting revealed the presence of multiple protein footprints in both the promoter and first intron of the EGFR gene in MDA-MB-468 cells, a breast cancer cell line that overexpresses the EGFR gene. The appearance of DH sites in intron 1 associated with high levels of EGFR expression suggests that these regions of the gene contain potential enhancer elements, while the absence of a DH site at the exon 1/intron 1 boundary when the gene is up-regulated suggests the action of a repressor that may block transcriptional elongation.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Eur Heart JHome page
U. H. Frey, M. Adamzik, E. Kottenberg-Assenmacher, H. Jakob, I. Manthey, M. Broecker-Preuss, L. Bergmann, G. Heusch, W. Siffert, J. Peters, et al.
A novel functional haplotype in the human GNAS gene alters G{alpha}s expression, responsiveness to {beta}-adrenoceptor stimulation, and peri-operative cardiac performance
Eur. Heart J., June 1, 2009; 30(11): 1402 - 1410.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
B. Brandt, S. Meyer-Staeckling, H. Schmidt, K. Agelopoulos, and H. Buerger
Mechanisms of egfr Gene Transcription Modulation: Relationship to Cancer Risk and Therapy Response
Clin. Cancer Res., December 15, 2006; 12(24): 7252 - 7260.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
R. Bianco, T. Troiani, G. Tortora, and F. Ciardiello
Intrinsic and acquired resistance to EGFR inhibitors in human cancer therapy
Endocr. Relat. Cancer, July 1, 2005; 12(Supplement_1): S159 - S171.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
M. L. Amador, D. Oppenheimer, S. Perea, A. Maitra, G. Cusati, C. Iacobuzio-Donahue, S. D. Baker, R. Ashfaq, C. Takimoto, A. Forastiere, et al.
An Epidermal Growth Factor Receptor Intron 1 Polymorphism Mediates Response to Epidermal Growth Factor Receptor Inhibitors
Cancer Res., December 15, 2004; 64(24): 9139 - 9143.
[Abstract] [Full Text] [PDF]


Home page
LupusHome page
C-M Huang, C-H Tsai, C-L Chen, C-P Chang, C-C Lai, and F-J Tsai
Epidermal growth factor receptor (EGFR) gene Bsr I polymorphism is associated with systemic lupus erythematosus
Lupus, October 1, 2004; 13(10): 773 - 776.
[Abstract] [PDF]


Home page
Cancer Res.Home page
H. Buerger, F. Gebhardt, H. Schmidt, A. Beckmann, K. Hutmacher, R. Simon, R. Lelle, W. Boecker, and B. Brandt
Length and Loss of Heterozygosity of an Intron 1 Polymorphic Sequence of egfr Is Related to Cytogenetic Alterations and Epithelial Growth Factor Receptor Expression
Cancer Res., February 1, 2000; 60(4): 854 - 857.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
F. Gebhardt, K. S. Zanker, and B. Brandt
Modulation of Epidermal Growth Factor Receptor Gene Transcription by a Polymorphic Dinucleotide Repeat in Intron 1
J. Biol. Chem., May 7, 1999; 274(19): 13176 - 13180.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H.-W. Lo and F. Ali-Osman
Genomic Cloning of hGSTP1*C, an Allelic Human Pi Class Glutathione S-Transferase Gene Variant and Functional Characterization of Its Retinoic Acid Response Elements
J. Biol. Chem., December 26, 1997; 272(52): 32743 - 32749.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.